Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Christina Bruss, Kerstin Kellner, Olaf Ortmann, Stephan Seitz, Gero Brockhoff, James A. Hutchinson & Anja Kathrin Wege. (2022) Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice. Cancers 14:9, pages 2214.
Crossref
Crossref
Anja Kathrin Wege, Tobias F. Dreyer, Attila Teoman, Olaf Ortmann, Gero Brockhoff & Holger Bronger. (2021) CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM). Cancers 13:10, pages 2459.
Crossref
Crossref
Yating Wu, Jianbo Zhu, Haifeng Liu & Hailiang Liu. (2021) Licochalcone A improves the cognitive ability of mice by regulating T- and B-cell proliferation. Aging 13:6, pages 8895-8915.
Crossref
Crossref
Juan A. Marín-Jiménez, Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro, Hui Yu, Chris J. Rivard, Xiaoguang Wang, Jessica C. Barkow, Degui Geng, Adwitiya Kar, Ashley Yingst, Dejene M. Tufa, James T. Dolan, Patrick J. Blatchford, Brian M. Freed, Raul M. Torres, Eduardo Davila, Jill E. Slansky, Roberta Pelanda, S. Gail Eckhardt, Wells A. Messersmith, Jennifer R. Diamond, Christopher H. Lieu, Michael R. Verneris, Jing H. Wang, Katja Kiseljak-Vassiliades, Todd M. Pitts & Julie Lang. (2021) Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Frontiers in Immunology 12.
Crossref
Crossref
Jean Paul Kamdem, Antonia Eliene Duarte, Mohammad Ibrahim, Kiven Erique Lukong, Luiz Marivando Barros & Thomas Roeder. (2020) Bibliometric analysis of personalized humanized mouse and Drosophila models for effective combinational therapy in cancer patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:10, pages 165880.
Crossref
Crossref
Renata Stripecke, Christian Münz, Jan Jacob Schuringa, Karl‐Dimiter Bissig, Brian Soper, Terrence Meeham, Li‐Chin Yao, James P Di Santo, Michael Brehm, Estefania Rodriguez, Anja Kathrin Wege, Dominique Bonnet, Silvia Guionaud, Kristina E Howard, Scott Kitchen, Florian Klein, Kourosh Saeb‐Parsy, Johannes Sam, Amar Deep Sharma, Andreas Trumpp, Livio Trusolino, Carol Bult & Leonard Shultz. (2020) Innovations, challenges, and minimal information for standardization of humanized mice. EMBO Molecular Medicine 12:7.
Crossref
Crossref
O, A. Bezborodova, A. A. Pankratov, E. R. Nemtsova, Yu. B. Venediktova, M. S. Vorontsova, G. N. Engalycheva & R. D. Syubaev. (2020) Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 10:2, pages 96-110.
Crossref
Crossref
Shilina Roman, Sanne Holt & Julia Schueler. (2020) Immuno-oncology: developing integrated approaches toward clinical success of biologics and small-molecule modulators. Future Drug Discovery 2:2.
Crossref
Crossref
Mumtaz Yaseen Balkhi. 2020. Basics of Chimeric Antigen Receptor (CAR) Immunotherapy. Basics of Chimeric Antigen Receptor (CAR) Immunotherapy
25
49
.
Roberto R. Rosato, Daniel Dávila-González, Dong Soon Choi, Wei Qian, Wen Chen, Anthony J. Kozielski, Helen Wong, Bhuvanesh Dave & Jenny C. Chang. (2018) Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Research 20:1.
Crossref
Crossref
Odd L. Gammelgaard, Mikkel G. Terp, Birgitte Preiss & Henrik J. Ditzel. (2018) Human cancer evolution in the context of a human immune system in mice. Molecular Oncology 12:10, pages 1797-1810.
Crossref
Crossref
Jing Wei, Huiyan Sun, Aimei Zhang, Xuejie Wu, Yuxiang Li, Jiawei Liu, Yanting Duan, Fengjun Xiao, Hua Wang, Ming Lv, Lisheng Wang & Chutse Wu. (2018) A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers. Cellular Immunology 331, pages 49-58.
Crossref
Crossref
Kylie Su Mei Yong, Zhisheng Her & Qingfeng Chen. (2018) Humanized Mice as Unique Tools for Human-Specific Studies. Archivum Immunologiae et Therapiae Experimentalis 66:4, pages 245-266.
Crossref
Crossref
Anja Kathrin Wege. (2018) Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy. BioDrugs 32:3, pages 245-266.
Crossref
Crossref
Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, Olaf Ortmann, Anja Wege & Gero Brockhoff. (2018) Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice. International Journal of Molecular Sciences 19:2, pages 563.
Crossref
Crossref
华文 孙. (2018) Effects of Recombinant Adenovirus-Mediated Co-Transfection of CEA Gene and EPO Geneon Promoting Hematopoietic Stem Cell Directly Producing Erythrocyte Vaccine against Colon Cancer. Hans Journal of Surgery 07:01, pages 9-18.
Crossref
Crossref
William K. Decker, Rodrigo F. da Silva, Mayra H. Sanabria, Laura S. Angelo, Fernando Guimarães, Bryan M. Burt, Farrah Kheradmand & Silke Paust. (2017) Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models. Frontiers in Immunology 8.
Crossref
Crossref
Qi-Xiang Li, Gerold Feuer, Xuesong Ouyang & Xiaoyu An. (2017) Experimental animal modeling for immuno-oncology. Pharmacology & Therapeutics 173, pages 34-46.
Crossref
Crossref
Ingunn Holen, Valerie Speirs, Bethny Morrissey & Karen Blyth. (2017)
In vivo
models in breast cancer research: progress, challenges and future directions
. Disease Models & Mechanisms 10:4, pages 359-371.
Crossref
Crossref
Tadashi Ashizawa, Akira Iizuka, Chizu Nonomura, Ryota Kondou, Chie Maeda, Haruo Miyata, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Kouji Maruyama, Ken Yamaguchi, Ikumi Katano, Mamoru Ito & Yasuto Akiyama. (2017) Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clinical Cancer Research 23:1, pages 149-158.
Crossref
Crossref
D. Surdez & E. Daudigeos-Dubus. (2016) PDX ou xénogreffe dérivée de la tumeur du patient, la renaissance d’un modèle oublié : son implication dans la recherche et la clinique de demain. Revue d'Oncologie Hématologie Pédiatrique 4:4, pages 237-245.
Crossref
Crossref
M.A. Brehm, R. Bortell, M. Verma, L.D. Shultz & D.L. Greiner. 2016. Translational Immunology. Translational Immunology
285
326
.
Boris Michael Holzapfel, Ferdinand Wagner, Laure Thibaudeau, Jean-Pierre Levesque & Dietmar Werner Hutmacher. (2015) Concise Review: Humanized Models of Tumor Immunology in the 21st Century: Convergence of Cancer Research and Tissue Engineering. Stem Cells 33:6, pages 1696-1704.
Crossref
Crossref
K.A. Lodhia, A.M. Hadley, P. Haluska & C.L. Scott. (2015) Prioritizing therapeutic targets using patient-derived xenograft models. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:2, pages 223-234.
Crossref
Crossref
Diana Behrens, Jana Rolff & Jens Hoffmann. 2016. New Approaches to Drug Discovery. New Approaches to Drug Discovery
203
221
.